Pioglitazone Decreases Carotid Intima-Media Thickness in Patients With Type 2 Diabetes Mellitus - Pioglitazone Decreases Carotid Intima-Media Thickness in Patients With Type 2 Diabetes

Description:

The goal of the trial was to evaluate the effect of treatment with pioglitazone compared with glimepiride therapy on carotid intima-media thickness (IMT) among patients with type 2 diabetes.